These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1283587)

  • 21. Antihypertensive therapy: new strategies beyond blood pressure control.
    Stumpe KO
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S1-4. PubMed ID: 1283182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current drug treatment and treatment patterns with antihypertensive drugs.
    Freis ED; Papademetriou V
    Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypertension in the elderly.
    Holzgreve H; Middeke M
    Drugs; 1993; 46 Suppl 2():24-31. PubMed ID: 7512477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of diuretics in antihypertensive therapy].
    De Nardo D; Frongillo D; Anselmo T; Delfino FA; Cannata D
    Clin Ter; 1995 Apr; 146(4):261-8. PubMed ID: 7796557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of antihypertensive drugs--involvement in the therapeutic choice.
    Luque-Otero M; Fernandez-Pinilla C
    Am J Cardiol; 1990 May; 65(17):33H-36H. PubMed ID: 2184651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should calcium antagonists be first line drugs in hypertension?
    Furberg CD; Psaty BM
    Herz; 1995 Dec; 20(6):365-9. PubMed ID: 8582696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of antihypertensive drugs on hypertension: associated risk factors.
    Weidmann P
    Cardiology; 1994; 85 Suppl 1():78-83. PubMed ID: 7743540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment goals in hypertension.
    Zanchetti A
    Am J Med; 1984 Feb; 76(2A):1-3. PubMed ID: 6702859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive drugs: diuretics and betablockers are the best assessed.
    Prescrire Int; 1999 Jun; 8(41):90-5. PubMed ID: 10558453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
    Donnelly R
    Clin Pharmacokinet; 1999; 37 Suppl 1():21-32. PubMed ID: 10491730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):737-40. PubMed ID: 8096658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension: are beta-blockers and diuretics appropriate first-line therapies?
    Wilson MD; Weart CW
    Ann Pharmacother; 1994 May; 28(5):617-25. PubMed ID: 7915151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive agents and cardiovascular risk factors.
    Fodor JG
    Clin Ther; 1986; 8(5):490-509. PubMed ID: 2876774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.